|
Name |
Mycoepoxydiene
|
Molecular Formula | C16H18O5 | |
IUPAC Name* |
[(2S,3S)-2-[(1R,6S,7R,8S)-8-methyl-9-oxabicyclo[4.2.1]nona-2,4-dien-7-yl]-6-oxo-2,3-dihydropyran-3-yl] acetate
|
|
SMILES |
C[C@@H]1[C@H]2C=CC=C[C@@H]([C@@H]1[C@H]3[C@H](C=CC(=O)O3)OC(=O)C)O2
|
|
InChI |
InChI=1S/C16H18O5/c1-9-11-5-3-4-6-12(20-11)15(9)16-13(19-10(2)17)7-8-14(18)21-16/h3-9,11-13,15-16H,1-2H3/t9-,11-,12+,13+,15-,16-/m1/s1
|
|
InChIKey |
MQZRLGPPQPUHBI-SUVXLDSESA-N
|
|
Synonyms |
Mycoepoxydiene; CHEMBL1290053; DTXSID101036970; [(2S,3S)-2-[(1R,6S,7R,8S)-8-methyl-9-oxabicyclo[4.2.1]nona-2,4-dien-7-yl]-6-oxo-2,3-dihydropyran-3-yl] acetate
|
|
CAS | 221898-91-5 | |
PubChem CID | 11300750 | |
ChEMBL ID | CHEMBL1290053 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 290.31 | ALogp: | 2.0 |
HBD: | 0 | HBA: | 5 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 61.8 | Aromatic Rings: | 3 |
Heavy Atoms: | 21 | QED Weighted: | 0.729 |
Caco-2 Permeability: | -4.67 | MDCK Permeability: | 0.00003710 |
Pgp-inhibitor: | 0.899 | Pgp-substrate: | 0.009 |
Human Intestinal Absorption (HIA): | 0.097 | 20% Bioavailability (F20%): | 0.904 |
30% Bioavailability (F30%): | 0.931 |
Blood-Brain-Barrier Penetration (BBB): | 0.948 | Plasma Protein Binding (PPB): | 19.63% |
Volume Distribution (VD): | 0.676 | Fu: | 62.69% |
CYP1A2-inhibitor: | 0.117 | CYP1A2-substrate: | 0.055 |
CYP2C19-inhibitor: | 0.024 | CYP2C19-substrate: | 0.116 |
CYP2C9-inhibitor: | 0.012 | CYP2C9-substrate: | 0.025 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.121 |
CYP3A4-inhibitor: | 0.118 | CYP3A4-substrate: | 0.367 |
Clearance (CL): | 8.996 | Half-life (T1/2): | 0.861 |
hERG Blockers: | 0.166 | Human Hepatotoxicity (H-HT): | 0.197 |
Drug-inuced Liver Injury (DILI): | 0.134 | AMES Toxicity: | 0.763 |
Rat Oral Acute Toxicity: | 0.942 | Maximum Recommended Daily Dose: | 0.925 |
Skin Sensitization: | 0.97 | Carcinogencity: | 0.212 |
Eye Corrosion: | 0.185 | Eye Irritation: | 0.2 |
Respiratory Toxicity: | 0.968 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003105 | 0.692 | D0T6WT | 0.239 | ||||
ENC003704 | 0.639 | D02FEM | 0.235 | ||||
ENC005196 | 0.475 | D06WTZ | 0.209 | ||||
ENC005194 | 0.470 | D0FX2Q | 0.208 | ||||
ENC005195 | 0.440 | D0H0ND | 0.205 | ||||
ENC003139 | 0.440 | D0M6VK | 0.204 | ||||
ENC003827 | 0.400 | D04LHJ | 0.202 | ||||
ENC003825 | 0.400 | D0P1WA | 0.198 | ||||
ENC003826 | 0.400 | D0D4IH | 0.196 | ||||
ENC003623 | 0.392 | D0OL7F | 0.194 |